BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30253743)

  • 1. The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus.
    Kim IY; Kim SS; Lee HW; Bae SS; Ha HK; Jung ES; Lee MY; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Lovett DH; Song SH
    BMC Nephrol; 2018 Sep; 19(1):248. PubMed ID: 30253743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy.
    Kim SS; Shin N; Bae SS; Lee MY; Rhee H; Kim IY; Seong EY; Lee DW; Lee SB; Kwak IS; Lovett DH; Song SH
    PLoS One; 2017; 12(2):e0171625. PubMed ID: 28178341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function.
    Wanga S; Ceron CS; Delgado C; Joshi SK; Spaulding K; Walker JP; Song S; Olson JL; Lovett DH
    PLoS One; 2015; 10(9):e0136276. PubMed ID: 26379248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cardiac expression of two isoforms of matrix metalloproteinase-2 in experimental diabetes mellitus.
    Lee HW; Lee SJ; Lee MY; Park MW; Kim SS; Shin N; Lovett DH; Bae SS; Ahn J; Park JS; Oh JH; Choi JH; Lee HC; Cha KS; Hong TJ; Song SH
    PLoS One; 2019; 14(8):e0221798. PubMed ID: 31461499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of two isoforms of matrix metalloproteinase-2 in aged mouse models of diabetes mellitus and chronic kidney disease.
    Rhee H; Han M; Kim SS; Kim IY; Lee HW; Bae SS; Ha HK; Jung ES; Lee MY; Seong EY; Lee DW; Lee SB; Lovett DH; Song SH
    Kidney Res Clin Pract; 2018 Sep; 37(3):222-229. PubMed ID: 30254846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury.
    Ceron CS; Baligand C; Joshi S; Wanga S; Cowley PM; Walker JP; Song SH; Mahimkar R; Baker AJ; Raffai RL; Wang ZJ; Lovett DH
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1166-F1183. PubMed ID: 28331061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel intracellular N-terminal truncated matrix metalloproteinase-2 isoform in skeletal muscle ischemia-reperfusion injury.
    Joshi SK; Lee L; Lovett DH; Kang H; Kim HT; Delgado C; Liu X
    J Orthop Res; 2016 Mar; 34(3):502-9. PubMed ID: 26213293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes.
    Sakai S; Yamamoto T; Takabatake Y; Takahashi A; Namba-Hamano T; Minami S; Fujimura R; Yonishi H; Matsuda J; Hesaka A; Matsui I; Matsusaka T; Niimura F; Yanagita M; Isaka Y
    J Am Soc Nephrol; 2019 Jun; 30(6):929-945. PubMed ID: 31040190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.
    Takamiya Y; Fukami K; Yamagishi S; Kaida Y; Nakayama Y; Obara N; Iwatani R; Ando R; Koike K; Matsui T; Nishino Y; Ueda S; Cooper ME; Okuda S
    Nephrol Dial Transplant; 2013 Jan; 28(1):55-62. PubMed ID: 23028104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.
    Nasrallah R; Xiong H; Hébert RL
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F278-84. PubMed ID: 16954344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE and ACE2 activity in diabetic mice.
    Wysocki J; Ye M; Soler MJ; Gurley SB; Xiao HD; Bernstein KE; Coffman TM; Chen S; Batlle D
    Diabetes; 2006 Jul; 55(7):2132-9. PubMed ID: 16804085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
    Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF
    Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation of the N-Terminal Truncated Isoform of Matrix Metalloproteinase-2 (NTT-MMP-2) and Its Presence in Renal and Cardiac Diseases.
    Cruz JO; Silva AO; Ribeiro JM; Luizon MR; Ceron CS
    Front Genet; 2021; 12():637148. PubMed ID: 33732288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models.
    Hagiwara H; Kaizu K; Uriu K; Noguchi T; Takagi I; Qie YL; Seki T; Ariga T
    Thromb Res; 2003; 111(4-5):301-9. PubMed ID: 14693179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients.
    Romanic AM; Burns-Kurtis CL; Ao Z; Arleth AJ; Ohlstein EH
    Am J Physiol Renal Physiol; 2001 Aug; 281(2):F309-17. PubMed ID: 11457723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
    Lo CS; Shi Y; Chenier I; Ghosh A; Wu CH; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Diabetes; 2017 Jul; 66(7):1964-1978. PubMed ID: 28424160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.